Rolf Ljung

Senior Professor
More filtering options
  1. 2020
  2. Long-term follow-up of neonatal intracranial haemorrhage in children with severe haemophilia

    Rolf Ljung & ICH study group, 2020 Jun 9, In : British Journal of Haematology.

    Research output: Contribution to journalArticle

  3. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study

    Kenet, G., Rolf Ljung, Rusen, L., Kerlin, B. A., Blanchette, V., Saulytė Trakymienė, S., Uscatescu, V., Beckmann, H., Tseneklidou-Stoeter, D. & Church, N., 2020 May, In : Thrombosis Research. 189, p. 96-101 6 p.

    Research output: Contribution to journalArticle

  4. Registries and databases: A European perspective

    Rolf C R Ljung, 2020 Apr, In : Haemophilia. 26 , Suppl 3, p. 26-28 2 p.

    Research output: Contribution to journalArticle

  5. Genetic screening of children with suspected inherited bleeding disorders

    Nadine Andersson, Rossing, M., Marcus Fager Ferrari, Gabrielaite, M., Leinøe, E., Rolf Ljung, Annika Mårtensson, Norström, E. & Eva Zetterberg, 2020, In : Haemophilia. 26, 2, p. 314-324 11 p.

    Research output: Contribution to journalArticle

  6. 2019
  7. Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

    van den Berg, H. M., Fischer, K., Carcao, M., Chambost, H., Kenet, G., Kurnik, K., Königs, C., Male, C., Santagostino, E., Rolf Ljung & PedNet Study Group, 2019 Jul 18, In : Blood. 134, 3, p. 317-320 4 p.

    Research output: Contribution to journalLetter

  8. Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening

    Manderstedt, E., Nilsson, R., Lind-Halldén, C., Rolf Ljung, Jan Astermark & Halldén, C., 2019 Apr 26, In : PLoS ONE. 14, 4, e0216179.

    Research output: Contribution to journalArticle

  9. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients

    Rolf Ljung, Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2019 Feb, In : European Journal of Haematology. 102, 2, p. 111-122

    Research output: Contribution to journalReview article

  10. Mode of delivery in hemophilia: Vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds

    Andersson, N. G., Chalmers, E. A., Kenet, G., Rolf Ljung, Mäkipernaa, A., Chambost, H. & PedNet Haemophilia Research Foundation, 2019, In : Haematologica. 104, 10, p. 2100-2106 7 p.

    Research output: Contribution to journalArticle

  11. Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

    Volkers, P., Hanschmann, K-M., Calvez, T., Chambost, H., Collins, P. W., Demiguel, V., Hart, D. P., Hay, C. R. M., Goudemand, J., Rolf Ljung, Palmer, B. P., Santagostino, E., van Hardeveld, E. M., van den Berg, M. & Keller-Stanislawski, B., 2019, In : Haemophilia. 25, 3, p. 398-407

    Research output: Contribution to journalArticle

  12. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Versloot, O., Erik Berntorp, Petrini, P., Rolf Ljung, Jan Astermark, Holmström, M., de Kleijn, P. & Fischer, K., 2019, In : Haemophilia. 25, 2, p. 244-251

    Research output: Contribution to journalArticle

  13. 2018
  14. Practical aspects of extended half-life products for the treatment of haemophilia

    Lambert, T., Benson, G., Dolan, G., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Zupančić-Šalek, S. & Santagostino, E., 2018 Sep, In : Therapeutic advances in hematology. 9, 9, p. 295-308 14 p.

    Research output: Contribution to journalReview article

  15. How I manage patients with inherited haemophilia A and B and factor inhibitors

    Rolf C.R. Ljung, 2018 Feb, In : British Journal of Haematology. 180, 4, p. 501-510

    Research output: Contribution to journalReview article

  16. Haemophilia B: Where are we now and what does the future hold?

    Dolan, G., Benson, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M. & Zupančić Šalek, S., 2018 Jan, In : Blood Reviews. 32, 1, p. 52-60

    Research output: Contribution to journalReview article

  17. Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management

    Benson, G., Auerswald, G., Dolan, G., Duffy, A., Hermans, C., Rolf Ljung, Morfini, M. & Šalek, S. Z., 2018, In : Blood Transfusion. p. 535-544

    Research output: Contribution to journalReview article

  18. Prevention and Management of Bleeding Episodes in Children with Hemophilia

    Rolf C.R. Ljung, 2018, In : Pediatric Drugs. 20, 5, p. 455-464

    Research output: Contribution to journalArticle

  19. 2017
  20. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

    Mancuso, M. E., Fischer, K., Santagostino, E., Oldenburg, J., Platokouki, H., Escuriola-Ettingshausen, C., Rivard, G. E., Cid, A. R., Carcao, M., Ljung, R., Petrini, P., Altisent, C., Kenet, G., Kurnik, K., Auerswald, G., Chambost, H., Mäkipernaa, A., Molinari, A. C., Williams, M., van den Berg, H. M. & 1 others, European Pediatric Network for Haemophilia Management (PedNet) the REMAIN (REal life MAnagement of children with INhibitors) Study Group, 2017 Dec, In : Thrombosis and Haemostasis. 117, 12, p. 2274-2282

    Research output: Contribution to journalArticle

  21. The care of a child with a newly diagnosed immune thrombocytopenia

    Rolf Ljung, 2017 Oct 1, In : Acta Paediatrica, International Journal of Paediatrics. 106, 10, p. 1554-1555

    Research output: Contribution to journalDebate/Note/Editorial

  22. Outcome measures for adult and pediatric hemophilia patients with inhibitors

    Hermans, C., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T., Mehdi Osooli & Zupančić Šalek, S., 2017 Aug 1, In : European Journal of Haematology. 99, 2, p. 103-111 9 p.

    Research output: Contribution to journalReview article

  23. Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.

    Šalek, S. Z., Auerswald, G., Benson, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Santagostino, E. & Lambert, T., 2017, In : Blood Transfusion. 15, p. 77-84

    Research output: Contribution to journalArticle

  24. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B

    K. Kihlberg, Strandberg, K., Rosén, S., R. Ljung & J. Astermark, 2017, In : Haemophilia. 23, 4, p. 620-627

    Research output: Contribution to journalArticle

  25. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment

    Gretenkort Andersson, N., Auerswald, G., Barnes, C., Carcao, M., Dunn, A. L., Fijnvandraat, K., Hoffmann, M., Kavakli, K., Kenet, G., Kobelt, R., Kurnik, K., Liesner, R., Mäkipernaa, A., Manco-Johnson, M. J., Mancuso, M. E., Molinari, A. C., Nolan, B., Perez Garrido, R., Petrini, P., Platokouki, H. E. & 3 others, Shapiro, A. D., Wu, R. & Rolf Ljung, 2017, In : British Journal of Haematology. 179, 2, p. 298-307

    Research output: Contribution to journalArticle

  26. Plasma products do not solve the inhibitor problem

    van den Berg, H. M., Pipe, S. & R. Ljung, 2017, In : Haemophilia. 23, 3, p. 346-347

    Research output: Contribution to journalDebate/Note/Editorial

  27. Primary prophylaxis in haemophilia care: Guideline update 2016

    Fischer, K. & Rolf Ljung, 2017, In : Blood Cells, Molecules, and Diseases. 67, p. 81-85

    Research output: Contribution to journalArticle

  28. 2016
  29. Aspects of prophylactic treatment of hemophilia

    Rolf Ljung, 2016 Oct 4, In : Thrombosis Journal. 14, S.1, 30.

    Research output: Contribution to journalReview article

  30. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

    Vepsäläinen, K., Lassila, R., Arola, M., Huttunen, P., Koskinen, S., R. Ljung, Lähteenmäki, P., Möttönen, M. & Riikonen, P., 2016 Sep 1, In : Haemophilia. 22, 5, p. 721-729 9 p.

    Research output: Contribution to journalArticle

  31. Phenotype and genotype comparisons in carriers of haemophilia A

    Olsson, A., R Ljung, Hellgren, M., E Berntorp & Baghaei, F., 2016 May, In : Haemophilia. 22, 3, p. 235–237

    Research output: Contribution to journalArticle

  32. Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors

    van den Berg, H. M., Hashemi, S. M., Fischer, K., Petrini, P., Rolf Ljung, Rafowicz, A., Carcao, M., Auerswald, G., Kurnik, K., Kenet, G. & Santagostino, E., 2016 Apr 1, In : Thrombosis and Haemostasis. 115, 4, p. 729-737 9 p.

    Research output: Contribution to journalArticle

  33. BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

    Rolf Ljung, Kenet, G., Mancuso, M. E., Kaleva, V., Rusen, L., Tseneklidou-Stoeter, D., Michaels, L. A., Shah, A., Hong, W. & Maas Enriquez, M., 2016, In : Haemophilia. 22, 3, p. 354-360

    Research output: Contribution to journalArticle

  34. Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.

    Fischer, K., Nijdam, A., Holmström, M., Petrini, P., Rolf Ljung, van der Schouw, Y. T. & Berntorp, E., 2016, In : Haemophilia.

    Research output: Contribution to journalArticle

  35. Origin of mutation in sporadic cases of severe haemophilia A in Sweden.

    Annika Mårtensson, Sten Ivarsson, Letelier, A., Manderstedt, E., Halldén, C. & Rolf Ljung, 2016, In : Clinical Genetics. 90, 1, p. 63-68

    Research output: Contribution to journalArticle

  36. Pain and pain management in haemophilia

    Auerswald, G., Dolan, G., Duffy, A., Hermans, C., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Lambert, T. & Šalek, S. Z., 2016, In : Blood Coagulation and Fibrinolysis. 27, 8, p. 845-854

    Research output: Contribution to journalReview article

  37. Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.

    Rolf Ljung, Fischer, K., Carcao, M., Santagostino, E., Manco-Johnson, M. J. & Mathew, P., 2016, In : Thrombosis and Haemostasis. 115, 5, p. 913-920

    Research output: Contribution to journalReview article

  38. 2015
  39. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

    Nijdam, A., Altisent, C., Carcao, M. D., Cid, A. R., Claeyssens-Donadel, S., Kurnik, K., Rolf Ljung, Nolan, B., Petrini, P., Platokouki, H., Rafowicz, A., Thomas, A. E. & Fischer, K., 2015, In : Haematologica. 100, 3, p. E84-E86

    Research output: Contribution to journalLetter

  40. Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?

    van den Berg, H. M. & Rolf Ljung, 2015, In : Blood. 126, 18, p. 2164-2165

    Research output: Contribution to journalLetter

  41. Hematologi

    Rolf Ljung, 2015, Neonatologi . Lagercrantz, H., Hellström-Westas, L. & Norman, M. (eds.). 2 ed. Lund: Studentlitteratur AB, p. 237-246 20

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  42. How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

    Nijdam, A., Kurnik, K., Liesner, R., Rolf Ljung, Nolan, B., Petrini, P. & Fischer, K., 2015, In : Haemophilia. 21, 4, p. 444-450

    Research output: Contribution to journalArticle

  43. Mutation analysis of Swedish haemophilia B families - high frequency of unique mutations.

    Annika Mårtensson, Letelier, A., Halldén, C. & Rolf Ljung, 2015, In : Haemophilia.

    Research output: Contribution to journalArticle

  44. Rationale for individualizing haemophilia care.

    Sørensen, B., Auerswald, G., Benson, G., Elezović, I., Felder, M., Lambert, T., Morfini, M., Remor, E., Salaj, P., Santagostino, E., Salek, S. Z. & Rolf Ljung, 2015, In : Blood Coagulation and Fibrinolysis. 26, 8, p. 849-857

    Research output: Contribution to journalReview article

  45. Switching treatments in haemophilia: is there a risk of inhibitor development?

    Santagostino, E., Auerswald, G., Benson, G., Dolan, G., Jimenez-Yuste, V., Lambert, T., Rolf Ljung, Morfini, M., Remor, E. & Salek, S. Z., 2015, In : European Journal of Haematology. 94, 4, p. 284-289

    Research output: Contribution to journalReview article

  46. Tailoring care to haemophilia patients' needs: which specialty and when?

    Morfini, M., Benson, G., Jiménez-Yuste, V., Rolf Ljung, Mannucci, P. M., Pasta, G., Remor, E. & Šalek, S. Z., 2015, In : Blood Transfusion. 13, 4, p. 644-650

    Research output: Contribution to journalArticle

  47. Various regimens for prophylactic treatment of patients with haemophilia

    Schwarz, R., Rolf Ljung & Ulf Tedgård, 2015, In : European Journal of Haematology. 94, p. 11-16

    Research output: Contribution to journalReview article

  48. 2014
  49. Similar bleeding phenotype in young children with haemophilia A or B: A cohort study

    Rodin Study group, 2014 Nov 1, In : Haemophilia. 20, 6, p. 747-755 9 p.

    Research output: Contribution to journalArticle

  50. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

    Olsson, A., Hellgren, M., Erik Berntorp, Rolf Ljung & Baghaei, F., 2014, In : Blood Coagulation and Fibrinolysis. 25, 5, p. 471-475

    Research output: Contribution to journalArticle

  51. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  52. Factor VIII therapy for hemophilia A: current and future issues

    Aledort, L., Rolf Ljung, Mann, K. & Pipe, S., 2014, In : Expert Review of Hematology. 7, 3, p. 373-385

    Research output: Contribution to journalReview article

  53. Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies?

    Lambert, T., Auerswald, G., Benson, G., Hedner, U., Jiménez-Yuste, V., Rolf Ljung, Morfini, M., Remor, E., Santagostino, E. & Zupančić Šalek, S., 2014, In : Thrombosis Research. 133, 6, p. 967-971

    Research output: Contribution to journalReview article

  54. Perinatal aspects of haemophilia

    Economou, M., Banov, L. & Rolf Ljung, 2014, In : European Journal of Haematology. 93, p. 21-25

    Research output: Contribution to journalReview article

Previous 1 2 3 4 5 Next